Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay N Cohn

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Circulation|September 22, 2010
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure TrialInder S Anand, Tibor Kempf, Thomas S Rector, et al.
Journal of the American College of Cardiology|September 19, 2006
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT TrialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 29, 2007
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure TrialJalal K Ghali, S William Tam, Keith C Ferdinand, et al.
Congestive Heart Failure (Greenwich, Conn.)|June 9, 2006
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFTJay N Cohn, Peter E Carson, Christopher O'Connor, et al.
Circulation|September 1, 2005
C-reactive protein in heart failure: prognostic value and the effect of valsartanInder S Anand, Roberto Latini, Viorel G Florea, et al.
Circulation|August 19, 2007
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failureRoberto Latini, Serge Masson, Inder S Anand, et al.
The American Journal of Medicine|January 25, 2006
Incremental prognostic value of changes in B-type natriuretic peptide in heart failureRoberto Latini, Serge Masson, Maylene Wong, et al.
Journal of Cardiac Failure|June 11, 2005
Clinical and analytical considerations in the study of health status in device trials for heart failureSharon-Lise T Normand, Thomas S Rector, James D Neaton, et al.
Journal of the American College of Cardiology|December 13, 2006
Outcomes by gender in the African-American Heart Failure TrialAnne L Taylor, JoAnn Lindenfeld, Susan Ziesche, et al.
Journal of the American College of Cardiology|January 9, 2007
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand, S William Tam, Thomas S Rector, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Circulation|September 22, 2010
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure TrialInder S Anand, Tibor Kempf, Thomas S Rector, et al.
Journal of the American College of Cardiology|September 19, 2006
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT TrialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 29, 2007
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure TrialJalal K Ghali, S William Tam, Keith C Ferdinand, et al.
Congestive Heart Failure (Greenwich, Conn.)|June 9, 2006
Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFTJay N Cohn, Peter E Carson, Christopher O'Connor, et al.
Circulation|September 1, 2005
C-reactive protein in heart failure: prognostic value and the effect of valsartanInder S Anand, Roberto Latini, Viorel G Florea, et al.
Circulation|August 19, 2007
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failureRoberto Latini, Serge Masson, Inder S Anand, et al.
The American Journal of Medicine|January 25, 2006
Incremental prognostic value of changes in B-type natriuretic peptide in heart failureRoberto Latini, Serge Masson, Maylene Wong, et al.
Journal of Cardiac Failure|June 11, 2005
Clinical and analytical considerations in the study of health status in device trials for heart failureSharon-Lise T Normand, Thomas S Rector, James D Neaton, et al.
Journal of the American College of Cardiology|December 13, 2006
Outcomes by gender in the African-American Heart Failure TrialAnne L Taylor, JoAnn Lindenfeld, Susan Ziesche, et al.
Journal of the American College of Cardiology|January 9, 2007
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand, S William Tam, Thomas S Rector, et al.
Pageof 18